Drugs Targeting the Glutamate System Warrant Continued Development for Schizophrenia, Study Finds
In the continuing effort to develop new medicines to treat schizophrenia, a team led by BBRF Scientific Council member Jeffrey Lieberman, M.D., and including nine other Council Members, BBRF grantees… Read More
Brainwave Study Reveals Oscillation Patterns That May Predict Transition to Psychosis
Researchers led by a BBRF grantee have reported progress in analyzing neural oscillations or “brainwaves” that may make it possible to clinically characterize which individuals at high risk of… Read More
Study Gauges Impact of Heavy, Chronic Cannabis Use on Cognition and Psychosis-Related Phenomena
Over recent years, legal restrictions on cannabis use have been lifted in many U.S. states. In 11 states and the District of Columbia the drug has not only been decriminalized but is currently… Read More
Progress is Reported on Research Exploring Use of Deep-Brain Stimulation for Psychosis, Schizophrenia
Investigators are reporting progress in research aiming to determine if deep-brain stimulation (DBS) can be used to help alleviate certain symptoms of psychosis and schizophrenia. Their results… Read More
Maternal Inflammation Early in Pregnancy May Raise Offspring’s Psychosis Risk
There is new evidence supporting the theory that children born of mothers who had inflammation during pregnancy have an elevated risk for developing a psychotic disorder by adulthood. The data… Read More